Author

Parvaneh Rastgou

Institution: Yale University

Observed institution: Yale University

OpenAlex ID: A5139864277

Revised lipid-lowering therapy guidelines in a nationally representative sample

2026 · Sridhar Mangalesh, Zafer Akman, et al. · American Heart Journal · 1

Abstract 10821: LDL-C Goal Attainment in Frail versus Non-Frail Older Adults with Atherosclerotic Cardiovascular Disease

2026 · Shefa Arya Nezhad, Armin Nouri, et al. · Circulation

Abstract 11178: Efficacy of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor versus Statin Monotherapy in Patients with Elevated Lipoprotein(a): A Target Trial Emulation

2026 · Golsa Babapour, Ishmum Chowdhury, et al. · Circulation

Abstract 10298: Comparative Outcomes of Transcatheter Tricuspid Edge-to-Edge Repair versus Transcatheter Tricuspid Valve Replacement: A Propensity-Matched Real-World Analysis

2026 · Kellen Round, Armin Nouri, et al. · Circulation

Abstract 11322: Maternal Triglyceride-Glucose Index and Adverse Pregnancy Outcomes: Association and Prognostic Performance in a Systematic Review and Meta-Analysis

2026 · Carolina Felippe, MARIA LEMOS, et al. · Circulation

Abstract 10879: Disparities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Adults with Schizophrenia and Obesity

2026 · Raiza Rossi, Sammudeen Ibrahim, et al. · Circulation

Abstract 11429: GLP-1 Receptor Agonists and Cardiovascular Outcomes in Postmenopausal Women with Overweight or Obesity Receiving Hormone Therapy

2026 · Parvaneh Rastgou, Kuan Yu Chi, et al. · Circulation

Abstract 11014: Glucagon-Like Peptide-1 Receptor Agonists and Clinical Outcomes in Antipsychotic-Treated Patients with Schizophrenia and Obesity: A Target Trial Emulation

2026 · Raiza Rossi, Sammudeen Ibrahim, et al. · Circulation

Abstract 5926: Neurocognitive Safety of Achieving LDL-C <30 mg/dL in Patients with Established ASCVD

2026 · Armin Nouri, Shefa Arya Nezhad, et al. · Circulation

Abstract 6625: Beta-Blocker Initiation and Clinical Outcomes in Older Adults with Heart Failure with Preserved Ejection Fraction: A Target Trial Emulation

2026 · Zafer Akman, Sammudeen Ibrahim, et al. · Circulation

Abstract 9161: Latent Biomarker Phenotypes in Older Adults Identify Distinct Patterns of Frailty, Cardiovascular Disease, and Mortality Risk

2026 · Shefa Arya Nezhad, Sridhar Mangalesh, et al. · Circulation

Abstract 9877: Population-Level Redistribution of Lipid-Lowering Therapy Recommendations Under Updated Dyslipidemia Guidelines

2026 · Sridhar Mangalesh, Zafer Akman, et al. · Circulation

Abstract 9727: Long-Term Risks of Heart Failure and Atrial Fibrillation Following Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis

2026 · Parvaneh Rastgou, Ana clara pimenta Servidoni, et al. · Circulation

Abstract 6899: Lipoprotein(a) and Residual Vascular Risk Among Patients Achieving Optimal LDL-C: A Real-World Cohort Analysis

2026 · Maryam Mojarrad Sani, Armin Nouri, et al. · Circulation

Abstract 9159: Postpartum Lipid Testing and Statin Initiation After Preeclampsia: A Nationwide Electronic Health Record Analysis

2026 · Parvaneh Rastgou, Kuan Yu Chi, et al. · Circulation

Abstract 7424: Early Hormone Replacement Therapy and Cognitive Outcomes in Postmenopausal Women

2026 · Armin Nouri, Caroline Hoeft, et al. · Circulation

Beyond LDL-C: Biomarker-Informed Risk Assessment and Management of Residual Cardiovascular Risk in the Era of Precision Prevention

2026 · Shefa Arya Nezhad, Armin Nouri, et al. · Diagnostics

Statin discontinuation in older adults: changing the conversation, not the default

2026 · Shefa Arya Nezhad, Parvaneh Rastgou, et al. · The Lancet Healthy Longevity

Works count: 18

Citation count: 1

H-index: 1

I10-index: